Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Author(s):
Gelder, M. van; Ziagkos, D.; Wreede, L. de; Biezen, A. van; Dreger, P.; Gramatzki, M.; Stelljes, M.; Andersen, N.S.; Schaap, N.; Vitek, A.; Beelen, D.; Lindstrom, V.; Finke, J.; Passweg, J.; Eder, M.; Machaczka, M.; Delgado, J.; Kruger, W.; Raida, L.; Socie, G.; Jindra, P.; Afanasyev, B.; Wagner, E.; Chalandon, Y.; Henseler, A.; Schoenland, S.; Kroger, N.; Schetelig, J.; CLL Subcomm Chronic Malignancies W; European Soc Blood Marrow Transpla
Published
2017
Publication type
Article / Letter to editor
del(17p)HLA-matched donorKinase- and BCL2 inhibitor refractoryNon-relapse mortalityRisk factor analysis
Date issued
2017-10-31
Language
English
Is part of
Clinical Lymphoma, Myeloma and Leukemia (2017), Vol. 17, no. 10, p. 667-+
hdl
1887/115783
doi
10.1016/j.clml.2017.06.007